본문으로 건너뛰기
← 뒤로

Aflatoxin and Liver Cancer in China: The Evolving Research Landscape.

Toxins 2026 Vol.18(2)

Chen JG, Kensler TW, Sun GJ, Zhu J, Lu JH, Pan D, Zhang YH, Groopman JD

📝 환자 설명용 한 줄

Aflatoxins, particularly aflatoxin B (AFB), are among the most potent naturally occurring carcinogens and remain a major food-borne hazard in parts of Asia and Africa.

이 논문을 인용하기

BibTeX ↓ RIS ↓
APA Chen JG, Kensler TW, et al. (2026). Aflatoxin and Liver Cancer in China: The Evolving Research Landscape.. Toxins, 18(2). https://doi.org/10.3390/toxins18020061
MLA Chen JG, et al.. "Aflatoxin and Liver Cancer in China: The Evolving Research Landscape.." Toxins, vol. 18, no. 2, 2026.
PMID 41745727

Abstract

Aflatoxins, particularly aflatoxin B (AFB), are among the most potent naturally occurring carcinogens and remain a major food-borne hazard in parts of Asia and Africa. China has generated a uniquely cohesive body of evidence connecting aflatoxin contamination to hepatocellular carcinoma (HCC), especially in settings where chronic hepatitis B virus (HBV) infection is highly prevalent and acts synergistically with aflatoxin exposure. Over five decades, field investigations and laboratory innovations-exemplified by long-term work in Qidong-have assembled a multi-layered causal chain spanning the following: (i) contamination monitoring in staple foods; (ii) quantification of internal dose and biologically effective dose using validated biomarkers (e.g., urinary AFB-N-guanine, AFM, and serum AFB-lysine albumin adducts); (iii) a characteristic molecular fingerprint in tumors and circulation (TP53 R249S); (iv) reversibility demonstrated through randomized intervention trials and policy-driven natural experiments. Chemoprevention and dietary interception studies (e.g., oltipraz, chlorophyllin, and broccoli sprout beverages) showed that enhancing detoxication pathways can lower biomarker burdens in exposed populations. At the population level, a sustained dietary transition from maize to rice, together with strengthened food governance, was accompanied by marked decreases in biomarker distributions and subsequent declines in HCC mortality in endemic regions. Nevertheless, regional heterogeneity, multi-mycotoxin co-exposure, and climate variability are expected to increase exposure volatility and complicate surveillance. Here, we translate and synthesize the Chinese evidence base, highlight biomarker-enabled monitoring and policy evaluation, and propose an integrated "5+1" prevention framework spanning source control, process detoxification, tiered governance, short-course interception, precision follow-up of high-risk individuals, and climate-sensitive early warning along the climate-agriculture-storage-processing-population (CAT-CSPP) chain.

MeSH Terms

Humans; China; Liver Neoplasms; Aflatoxins; Food Contamination; Animals; Carcinoma, Hepatocellular; Aflatoxin B1